Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > People still write in capital Letters Lol
View:
Post by Blairman1 on Jun 03, 2019 12:34am

People still write in capital Letters Lol

Amarin went from $2.80 for over a year to a high of $23 US Abs settled around $18 US If you really are an Acasti Shareholder , then u think a 500% mive from here is similar and likely for Acasti. Your such a LOSER BOOZEHOUND OR WHATEVER YOUR ALIAS NAMES ARE
Comment by boozehound3 on Jun 03, 2019 11:31am
well blairman           as you can see from the sell off today there are some smart people out there amarin will fall just as far as it went up if the fda wants another study and acasti, well it will kill them. wake up and do some research even francine is on board now
Comment by Francine01 on Jun 03, 2019 1:12pm
WTF!? The seeking alpha article is an anonymous short attack, its have 0% credibility. Will you write everytime the SP fluctuation by 2% cents? Acasti value will be shown this fall. For now its an amazing deal. You should cover your short shortly. GLTA
Comment by boozehound3 on Jun 03, 2019 1:25pm
good to hear from you francine         not everything is a short attack    the arcticle was absolutly credible  all points fda will look at          amarin was vauge on corn oil issue watch for insider selling at amarin             september will be the deciding factor i know you are trimming your position ...more  
Comment by Francine01 on Jun 03, 2019 5:14pm
lolololol. The mineral placebo was adressed by the FDA a long time ago. Its totaly irrelevant. My original cost with Amarin is 2.75$ I have no plan to sell under $30, there is still plenty of upside coming. Same for Acasti. HDL/LDL controled with Omega3 is the future. I won't sell you my shares.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities